LNSR Q1 2025 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$14M+33.7% YoY

Gross Profit

$7M50.3% margin

Operating Income

-$6M-40.9% margin

Net Income

-$27M-193.1% margin

EPS (Diluted)

$-2.32

QoQ Revenue Growth

-15.4%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$654,000

Balance Sheet

Total Assets

$73M

Total Liabilities

$95M

Stockholders' Equity

-$22M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$14M	$11M	+33.7%
Gross Profit	$7M	$5M	+32.2%
Operating Income	-$6M	-$3M	-103.2%
Net Income	-$27M	-$2M	-1167.7%

Revenue Segments

Product

$11M89%

Service

$1M11%

Geographic Segments

UNITED STATES

$7M55%

Asia Excluding South Korea

$3M25%

Europe

$2M18%

KOREA, REPUBLIC OF

$188,0002%

Other Geographical Region

$67,0001%